“…Hyperkeratosis of the follicular epithelia and keratin plug formation are thought to play important roles in the primary stage of the autoinflammatory pathogenesis of HS cases with mutations in the γ-secretase genes NCSTN, PSENEN and PSEN1 ( 7 ). However, variants in genes related to autoinflammation (e.g., MEFV, NOD2, LPIN2, NLRP3, NLRP12, PSMB8, MVK, IL1RN, PSTPIP1 ) have been reported to be associated with HS ( 8 ), and the variants probably cause autoinflammation preceding the follicular hyperkeratosis in the pathogenesis of HS. The fact that adalimumab, infliximab, anakinra, ustekinumab and other biologics are effective against HS may support the concept that HS should be categorized as an AiKD.…”